# Pharmacokinetics of Nalbuphine Injection

> **NCT03826316** · PHASE4 · COMPLETED · sponsor: **Yung Shin Pharm. Ind. Co., Ltd.** · enrollment: 14 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Nalbuphine

## Key facts

- **NCT ID:** NCT03826316
- **Lead sponsor:** Yung Shin Pharm. Ind. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-15
- **Primary completion:** 2018-11-22
- **Final completion:** 2019-01-15
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2019-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03826316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03826316, "Pharmacokinetics of Nalbuphine Injection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03826316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*